Skip to main content
Article thumbnail
Location of Repository

Characterization of the Interferon-Producing Cell in Mice Infected with Listeria monocytogenes

By Silvia Stockinger, Renate Kastner, Elisabeth Kernbauer, Andreas Pilz, Sandra Westermayer, Benjamin Reutterer, Didier Soulat, Gabriele Stengl, Claus Vogl, Theresa Frenz, Zoe Waibler, Tadatsugu Taniguchi, Thomas Rülicke, Ulrich Kalinke, Mathias Müller and Thomas Decker


Production of type I interferons (IFN-I, mainly IFNα and IFNβ) is a hallmark of innate immune responses to all classes of pathogens. When viral infection spreads to lymphoid organs, the majority of systemic IFN-I is produced by a specialized “interferon-producing cell” (IPC) that has been shown to belong to the lineage of plasmacytoid dendritic cells (pDC). It is unclear whether production of systemic IFN-I is generally attributable to pDC irrespective of the nature of the infecting pathogen. We have addressed this question by studying infections of mice with the intracellular bacterium Listeria monocytogenes. Protective innate immunity against this pathogen is weakened by IFN-I activity. In mice infected with L. monocytogenes, systemic IFN-I was amplified via IFN-β, the IFN-I receptor (IFNAR), and transcription factor interferon regulatory factor 7 (IRF7), a molecular circuitry usually characteristic of non-pDC producers. Synthesis of serum IFN-I did not require TLR9. In contrast, in vitro–differentiated pDC infected with L. monocytogenes needed TLR9 to transcribe IFN-I mRNA. Consistent with the assumption that pDC are not the producers of systemic IFN-I, conditional ablation of the IFN-I receptor in mice showed that most systemic IFN-I is produced by myeloid cells. Furthermore, results obtained with FACS-purified splenic cell populations from infected mice confirmed the assumption that a cell type with surface antigens characteristic of macrophages and not of pDC is responsible for bulk IFN-I synthesis. The amount of IFN-I produced in the investigated mouse lines was inversely correlated to the resistance to lethal infection. Based on these data, we propose that the engagement of pDC, the mode of IFN-I mobilization, as well as the shaping of the antimicrobial innate immune response by IFN-I differ between intracellular pathogens

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2007). Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses.
  2. (2008). Bacterial entry to the splenic white pulp initiates antigen presentation to CD8+ T cells.
  3. (1999). Conditional gene targeting in macrophages and granulocytes using LysMcre mice.
  4. (2003). Crosspriming of CD8+ T cells stimulated by virus-induced type I interferon.
  5. (2002). Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling.
  6. (2006). Cutting edge: Role of TANK-binding kinase 1 and inducible IkappaB kinase in IFN responses against viruses in innate immune cells.
  7. (2007). DAI (DLM1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.
  8. (2006). Dendritic cells in a mature age.
  9. (2006). Differential expansion, activation and effector functions of conventional and plasmacytoid dendritic cells in mouse tissues transiently infected with Listeria monocytogenes.
  10. (2008). Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
  11. (2006). Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.
  12. (2007). How important are Toll-like receptors for antimicrobial responses?
  13. (2004). IFN Regulatory Factor 3-Dependent Induction of Type I IFNs by Intracellular Bacteria Is Mediated by a TLR- and Nod2-Independent Mechanism.
  14. (1985). In vitro natural cellmediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
  15. (2005). Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
  16. (2005). Interferon gene regulation: not all roads lead to Tolls.
  17. (2007). Interferonregulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells.
  18. (2004). Interferons, interferon-like cytokines, and their receptors.
  19. (2006). Intracellular pattern recognition receptors in the host response.
  20. (2005). IRF-7 is the master regulator of type-I interferon-dependent immune responses.
  21. (2006). IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
  22. (2008). Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo.
  23. (1992). L. monocytogenes–induced actin assembly requires the actA gene product, a surface protein.
  24. (2006). Listeria monocytogenes: a multifaceted model.
  25. (2001). Listeria pathogenesis and molecular virulence determinants.
  26. (2007). Listeriolysin O: a phagosome-specific lysin.
  27. (2006). Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens.
  28. (2004). Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.
  29. (1998). Neutrophil-Kupffer cell interaction in host defenses to systemic infections.
  30. (2008). Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes.
  31. (2005). Plasmacytoid dendritic cells—virus experts of innate immunity.
  32. (2003). Prakash A
  33. (2002). Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes.
  34. (2002). Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units.
  35. (2008). Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells.
  36. (2002). Stats: transcriptional control and biological impact.
  37. (2005). The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.
  38. (2007). The role of type I interferons in TLR responses.
  39. (2005). The yin and yang of type I interferon activity in bacterial infection.
  40. (2005). Tissue-specific positive feedback requirements for production of type l interferon following virus infection.
  41. (2004). Toll-like receptor signalling.
  42. (2007). Toll-like receptors and Type I interferons.
  43. (2008). Type I IFN are host modulators of strain-specific Listeria monocytogenes virulence.
  44. (2007). Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria.
  45. (2004). Type I interferon production enhances susceptibility to Listeria monocytogenes infection.
  46. (2004). Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.
  47. (2001). Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.
  48. (2002). Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo.
  49. (2008). Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.